Literature DB >> 10202312

The lung in the immunocompromised patient. Infectious complications Part 1.

R P Baughman1.   

Abstract

Pulmonary infections are a major cause of morbidity and mortality in the immunosuppressed patient. Among the infections encountered are Pneumocystis carinii, mycobacterial, fungal, and bacterial infection. In this review, we will discuss these various possible infections, their frequency of occurrence, and their clinical presentation in the various immunosuppressed groups.

Entities:  

Mesh：

Year:  1999        PMID： 10202312     DOI： 10.1159/000029349

Source DB:  PubMed          Journal:  Respiration        ISSN： 0025-7931            Impact factor:   3.580


  12 in total

Review 1.  Partners in crime: co-infections in the developing world.

Authors:  A Pennycook; P Openshaw; T Hussell
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol.

Authors:  Cristina Danés; Julián González-Martín; Tomàs Pumarola; Ana Rañó; Natividad Benito; Antoni Torres; Asunción Moreno; Montserrat Rovira; Jorge Puig de la Bellacasa
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.

Authors:  A Rañó; C Agustí; P Jimenez; J Angrill; N Benito; C Danés; J González; M Rovira; T Pumarola; A Moreno; A Torres
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

4.  In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.

Authors:  Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Giuseppina D'Amato; Carmela Silvestri; Maria Simona Del Prete; Alberto Licci; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 5.  [Immunodeficiency and immunocompromised patients. Opportunistic infection of the lungs].

Authors:  F Länger; H H Kreipe
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

6.  Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.

Authors:  R M Schiffelers; G Storm; M T ten Kate; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  Transbronchial cryobiopsy in immunocompromised patients with pulmonary infiltrates: a pilot study.

Authors:  Oren Fruchter; Ludmila Fridel; Dror Rosengarten; Nader Abed-el Rahman; Mordechai R Kramer
Journal:  Lung       Date:  2013-09-26       Impact factor: 2.584

8.  Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.

Authors:  Norbert Degousee; David J Kelvin; Gerd Geisslinger; David M Hwang; Eva Stefanski; Xing-Hua Wang; Ali Danesh; Carlo Angioni; Helmut Schmidt; Thomas F Lindsay; Michael H Gelb; James Bollinger; Christine Payré; Gérard Lambeau; Jonathan P Arm; Armand Keating; Barry B Rubin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

9.  Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.

Authors:  Barry B Rubin; Gregory P Downey; Adeline Koh; Norbert Degousee; Farideh Ghomashchi; Laxman Nallan; Eva Stefanski; Denis W Harkin; Chunxiang Sun; Brian P Smart; Thomas F Lindsay; Vera Cherepanov; Eric Vachon; David Kelvin; Martin Sadilek; Glenn E Brown; Michael B Yaffe; Jonathan Plumb; Sergio Grinstein; Michael Glogauer; Michael H Gelb
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

10.  Microbial aetiologic agents associated with pneumonia in immunocompromised hosts.

Authors:  Theophilus K C Udeani; Joy Moses; Adanma Uzoechina; Ameh E J Okwori; Chigozie N Okwosa
Journal:  Afr J Infect Dis       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.